Abstract:Background: In recent years, observational studies have provided evidence supporting a potential association between autism spectrum disorder (ASD) and gut microbiota. However, the causal effect of gut microbiota on ASD remains unknown. Methods: We identified the summary statistics of 206 gut microbiota from the MiBioGen study, and ASD data were obtained from the latest Psychiatric Genomics Consortium Genome-Wide Association Study (GWAS). We then performed Mendelian randomization (MR) to determine a causal relationship between the gut microbiota and ASD using the inverse variance weighted (IVW) method, simple mode, MR-Egger, weighted median, and weighted model. Furthermore, we used Cochran's Q test, MR-Egger intercept test, Mendelian Randomization Pleiotropy RESidual Sum and Outlier (MR-PRESSO), and leave-one-out analysis to identify heterogeneity and pleiotropy. Moreover, the Benjamin-Hochberg approach (FDR) was employed to assess the strength of the connection between exposure and outcome. We performed reverse MR analysis on the gut microbiota that were found to be causally associated with ASD in the forward MR analysis to examine the causal relationships. The enrichment analyses were used to analyze the biological function at last. Results: Based on the results of IVW results, genetically predicted family Prevotellaceae and genus Turicibacter had a possible positive association with ASD (IVW OR=1.14, 95% CI: 1.00-1.29, P =3.7×10 −2 ), four gut microbiota with a potential protective effect on ASD: genus Dorea (OR=0.81, 95% CI: 0.69-0.96, P =1.4×10 −2 ), genus Ruminiclostridium5 (OR=0.81, 95% CI: 0.69-0.96, P =1.5×10 −2 ), genus Ruminococcus1 (OR=0.83, 95% CI: 0.70-0.98, P =2.8×10 −2 ), and genus Sutterella (OR=0.82, 95% CI: 0.68-0.99, P =3.6×10 −2 ). After FDR multiple-testing correction we further observed that there were two gut microbiota still have significant relationship with ASD: family Prevotellaceae (IVW OR=1.24; 95% CI: 1.09-1.40, P =9.2×10 -4 ) was strongly positively correlated with ASD and genus RuminococcaceaeUCG005 (IVW OR=0.78, 95% CI: 0.67-0.89, P =6.9×10 −4 ) was strongly negatively correlated with ASD. The sensitivity analysis excluded the influence of heterogeneity and horizontal pleiotropy. Conclusion: Our findings reveal a causal association between several gut microbiomes and ASD. These results deepen our comprehension of the role of gut microbiota in ASD's pathology, providing the foothold for novel ideas and theoretical frameworks to prevent and treat this patient population in the future.

Unique and Enriched Microbes and Their Potential “allies and Foes” in the Human Gut Microbiomes of ASD Patients

The many faces of microbiota-gut-brain axis in autism spectrum disorder

A comprehensive diversity analysis on the gut microbiomes of ASD patients: from alpha, beta to gamma diversities

Analysis of gut microbiota profiles and microbe-disease associations in children with autism spectrum disorders in China

The role of microbiota in autism spectrum disorder: A bibliometric analysis based on original articles

Potential of gut microbiome for detection of autism spectrum disorder

Revealing the gut microbiome mystery: A meta-analysis revealing differences between individuals with autism spectrum disorder and neurotypical children

Microbiome-Specific Statistical Modeling Identifies Interplay Between Gastrointestinal Microbiome and Neurobehavioral Outcomes in Patients With Autism: A Case Control Study

Gut microbiota and autism spectrum disorders: a bidirectional Mendelian randomization study

Multikingdom and functional gut microbiota markers for autism spectrum disorder

Multi-level analysis of the gut–brain axis shows autism spectrum disorder-associated molecular and microbial profiles

Gut microbiome and serum amino acid metabolome alterations in autism spectrum disorder

Alteration of the gut microbiota profile in children with autism spectrum disorder in China

Correlation of Gut Microbiome Between ASD Children and Mothers and Potential Biomarkers for Risk Assessment.

Alteration of Gut Microbiota: New Strategy for Treating Autism Spectrum Disorder

Comparison of gut microbiota in autism spectrum disorders and neurotypical boys in China: A case-control study

Changes in the Gut Microbiota of Children with Autism Spectrum Disorder

Deviated and early unsustainable stunted development of gut microbiota in children with autism spectrum disorder

Gut Microbial Profile Is Associated With the Severity of Social Impairment and IQ Performance in Children With Autism Spectrum Disorder

Altered gut microbial profile is associated with abnormal metabolism activity of Autism Spectrum Disorder

Alteration of Gut Microbiota-Associated Epitopes in Children with Autism Spectrum Disorders